SANOFI CONS HEALTHC IND L Cash Flow Conversion Efficiency
SANOFI CONS HEALTHC IND L cash flow conversion efficiency. Based on the latest financial reports, SANOFI CONS HEALTHC IND L (SANOFICONR) has a cash flow conversion efficiency ratio of 0.409x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.57 Billion ≈ $16.97 Million USD) by net assets (Rs3.84 Billion ≈ $41.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of SANOFI CONS HEALTHC IND L (2023–2025)
Cash flow conversion efficiency of SANOFI CONS HEALTHC IND L from 2023 to 2025. This chart illustrates how SANOFI CONS HEALTHC IND L's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SANOFI CONS HEALTHC IND L stock quote for real-time trading data and today's change.
SANOFI CONS HEALTHC IND L Cash Flow Conversion Ratio Explained
SANOFI CONS HEALTHC IND L cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
SANOFI CONS HEALTHC IND L Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SANOFI CONS HEALTHC IND L ranked by their cash flow conversion efficiency. Also see market value of SANOFI CONS HEALTHC IND L for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
|
-2.005x |
|
CGN Nuclear Technology Development Co Ltd
SHE:000881
|
0.017x |
|
Beijing Hualu Baina Film TV
SHE:300291
|
0.001x |
|
Beijing eGOVA
SHE:300075
|
-0.007x |
|
Fujian Boss Software Development Co Ltd
SHE:300525
|
0.016x |
|
Artis Real Estate Investment Trust
TO:AX-UN
|
0.040x |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
N/A |
|
Netac Tech
SHE:300042
|
-0.110x |
Annual Cash Flow Conversion Efficiency for SANOFI CONS HEALTHC IND L (2023–2025)
The table below shows the annual cash flow conversion efficiency of SANOFI CONS HEALTHC IND L from 2023 to 2025. Review cash generation quality of SANOFI CONS HEALTHC IND L to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rs3.84 Billion ≈ $41.53 Million |
Rs1.88 Billion ≈ $20.33 Million |
0.490x | -69.55% |
| 2024-12-31 | Rs2.73 Billion ≈ $29.52 Million |
Rs4.39 Billion ≈ $47.48 Million |
1.608x | +83558.24% |
| 2023-12-31 | Rs2.08 Billion ≈ $22.45 Million |
Rs-4.00 Million ≈ $-43.26K |
-0.002x | -- |
About SANOFI CONS HEALTHC IND L
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was in… Read more